News

Neurology model will help power real-world evidence generation into the rare-disease patient journey.

Newly combined organization to provide pharmacovigilance solution focused on current and future requirements of the life sciences industry.

Specialty area to focus on major depression, schizophrenia, multiple sclerosis, and more.

Regulatory bodies in Europe offer guidance for sponsors in light of recent events.

Organizations will decentralize patient assessments in preclinical Alzheimer’s disease research.

With Veeva Development Cloud, Boehringer Ingelheim aims to accelerate the development of novel medicines.

New monitoring and recording technology will further compliment existing library of DCT, ePRO tools.

Collaboration on new AI-driven technology will enhance THREAD's existing platform.

Will bridge critical gaps in care for people of color with moderate to severe plaque psoriasis.

Industry must act now to minimize effects of COVID-19 on clinical research.

AMCR to utilize ScienceMedia's protocol compliance management solution.

Platform to alleviate logistical challenges with patients.

FDA recently approved the disease-modifying therapy for adults with hemolytic anemia caused by PK (pyruvate kinase) deficiency.

New white paper assess implications of technology on DCTs.

Almost 5% of global drugs trials are conducted in Ukraine and Russia and are now on hold.

Calyx brings medical Imaging, IRT, and EDC solution delivery to ProTrials customers.

15.6M DKK will be used to bring trials closer to patients in Denmark.

FDA compliant operating system to deliver longitudinal health data and patient engagement.

The latest business and people happenings from the past month, all in one place.

Emmes bolsters rare disease research capabilities.

New collaboration will drive diversity in clinical trials.

New facilities and services to meet growing demand for Phase I studies.

MHRA shares CluePoints case study to demonstrate the value of statistical monitoring in clinical trial oversight and monitoring.

Data to inform prevention of sudden cardiac death in the young and pediatric product development.

CRO chosen as provider of medical imaging, IRT, and EDC.

New site to focus on on psychiatric, cannabis, and psychedelic studies.

SMART on FHIR technology to reduce need for manual input of patient data.

New edition of bi-monthly report focuses on cost variation and mis-estimation in clinical trial budgets.